Form 4: Klaviyo CEO Andrew Bialecki Executes Stock Sale
Statement of Changes in Beneficial Ownership
Klaviyo Co-CEO Andrew Bialecki sold 200,000 shares of Series A Common Stock pursuant to a pre-arranged Rule 10b5-1 trading plan.
Summary
- Co-CEO Andrew Bialecki converted 200,000 shares of Series B Common Stock into Series A Common Stock.
- The converted shares were subsequently sold in two tranches on April 14, 2026.
- The first tranche of 109,142 shares was sold at a weighted average price of $17.39.
- The second tranche of 90,858 shares was sold at a weighted average price of $16.94.
- The transactions were executed under a Rule 10b5-1 trading plan adopted on May 20, 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed through a pre-planned 10b5-1 program and represents a small fraction of the executive's total holdings.
Positives
- The sale was conducted via a pre-established Rule 10b5-1 plan, which is a standard mechanism for insiders to sell stock without triggering concerns regarding non-public information.
Negatives
- The transaction represents a divestment of 200,000 shares by the Co-CEO, which may be perceived as a reduction in direct equity stake.
Risks
- Insider selling activity can sometimes influence market sentiment negatively, regardless of the pre-planned nature of the trades.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Industry Context
StockSavvy.ai notes that insider selling via 10b5-1 plans is a common practice among technology executives to manage personal liquidity and diversification, and generally does not signal a lack of confidence in the company's long-term prospects.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for corporate officers to conduct orderly divestments.
- The scale of the sale is relatively minor compared to the reporting person's total beneficial ownership of 67,344,118 shares.
Related Party Transactions
- The filing discloses holdings by various trusts associated with the reporting person, including the Andrew P. Bialecki Grantor Retained Annuity Trust I of 2023 and the Elizabeth L. Bialecki Irrevocable GST Trust of 2023.
Stakeholder Impact
- Minimal impact expected as the sale was pre-planned and represents a small portion of the total outstanding shares held by the insider.
Next Steps
- Continued monitoring of future Form 4 filings for further insider activity.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date the Rule 10b5-1 trading plan was adopted. |
| 04/14/2026 | Date of the reported stock conversion and sale transactions. |
| 04/16/2026 | Date the Form 4 was filed with the SEC. |
Keywords
Klaviyo, KVYO, Insider Trading, Form 4, Andrew Bialecki, Stock Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.